Mr. Girard is the founder of Christian Girard E.I.R.L., d/b/a Orphan Drugs Industry Advisory & Intelligence with more than 20 years of domestic and cross-border industry and management consulting experience. He has extensive experience in operations, business development, funding and industry/patients organizations interactions in the rare diseases space. Mr. Girard is a frequent speaker at orphan drugs conferences and has published numerous articles on these topics. Based in France, he is a graduate from ESCP Europe, a leading business school.
